32.96 0 (0%) | 12-31 19:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 38.62 | 1-year : | 45.11 |
Resists | First : | 33.06 | Second : | 38.62 |
Pivot price | 32.95 | |||
Supports | First : | 32.92 | Second : | 32.84 |
MAs | MA(5) : | 32.95 | MA(20) : | 32.95 |
MA(100) : | 32.93 | MA(250) : | 29.54 | |
MACD | MACD : | 0 | Signal : | 0 |
%K %D | K(14,3) : | 52.1 | D(3) : | 52.1 |
RSI | RSI(14): 58.7 | |||
52-week | High : | 33.93 | Low : | 20.9 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ NTUS ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 94 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 33.15 - 33.31 | 33.31 - 33.44 |
Low: | 32.38 - 32.61 | 32.61 - 32.79 |
Close: | 32.65 - 32.99 | 32.99 - 33.26 |
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.
Thu, 21 Jul 2022
ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value - GlobeNewswire
Tue, 19 Apr 2022
ArchiMed to Acquire Natus Medical Inc - The Hearing Review
Mon, 18 Apr 2022
NATUS MEDICAL ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of NTUS and Encourages Investors to ... - GlobeNewswire
Mon, 18 Apr 2022
Why Natus Medical Stock Surged Today - The Motley Fool
Tue, 04 Jan 2022
VREX: 4 A-Rated Small-Cap Stocks to Buy for 2022, According to POWR Ratings - StockNews.com
Wed, 17 Nov 2021
Natus Medical Adds Starkey Hearing to Supporting Manufacturers for Otoscan - The Hearing Review
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 34 (M) |
Shares Float | 34 (M) |
Held by Insiders | 1.9 (%) |
Held by Institutions | 95.1 (%) |
Shares Short | 1,460 (K) |
Shares Short P.Month | 1,170 (K) |
EPS | 0.5 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 12.51 |
Profit Margin | 2.6 % |
Operating Margin | 6.4 % |
Return on Assets (ttm) | 3.3 % |
Return on Equity (ttm) | 3 % |
Qtrly Rev. Growth | 4.1 % |
Gross Profit (p.s.) | 8.19 |
Sales Per Share | 14 |
EBITDA (p.s.) | 1.7 |
Qtrly Earnings Growth | -20.3 % |
Operating Cash Flow | 48 (M) |
Levered Free Cash Flow | 53 (M) |
PE Ratio | 65.91 |
PEG Ratio | 1 |
Price to Book value | 2.63 |
Price to Sales | 2.35 |
Price to Cash Flow | 23.35 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |